Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
Globe Life Inc. reported insider stock transactions by Co-Chairman, CEO and Director Frank M. Svoboda on December 16, 2025. He exercised an employee stock option to acquire 12,500 shares of common stock at an exercise price of $82.56 per share, then sold portions of those shares on the same day.
The reported sales totaled 6,579 shares at a price shown as $140.2742 per share, with actual sale prices ranging from $139.65 to $140.64, and an additional 2,800 shares at $140.7887 per share, with prices ranging from $140.65 to $141.03. After these transactions, he directly owned 35,868 Globe Life common shares, plus 134,898 shares held through a family trust and 1,947.384 shares through a 401(k) plan.
Globe Life Inc. executive Michael Shane Henrie, SVP & Chief Accounting Officer, reported an option exercise and share sale on 07/29/2025. He exercised employee stock options for 3,250 shares of common stock at $103.23 per share, then sold 3,250 shares at a weighted average price of $139.7526, with individual trades between $139.67 and $139.90.
After these transactions, he directly owned 3,040 Globe Life shares and held an additional 152.182 shares indirectly through a 401(k) plan. The amended report also corrects the amount of underlying securities shown for the employee stock option in Table II, while noting that the original report was filed on time.
Globe Life Inc. officer Michael Shane Henrie, the company’s SVP and Chief Accounting Officer, reported exercising stock options and selling common shares on 12/12/2025.
He exercised 3,065 employee stock options at an exercise price of $120.49 per share and sold 3,065 shares of Globe Life common stock at a weighted average price of $139.0997 per share, with sale prices ranging from $138.87 to $139.325. After these transactions, he directly owned 3,040 shares of common stock and indirectly held 154.904 shares through a 401(k) plan. The Form 4 also lists 3,065 employee stock options expiring on 02/22/2030, which were first exercisable as to 50% of the shares on 02/22/2025 and the remaining 50% on 02/22/2026.
Globe Life Inc. filed a notice of proposed sale of common stock under Rule 144. The filing covers 12,500 shares of common stock to be sold through APEX Clearing in Dallas on or about 12/12/2025, with an indicated aggregate market value of 1,740,250.00. The shares relate to a prior stock option exercise dated 02/28/2019 involving 65,000 securities acquired from Globe Life Inc.
The filing notes that 79,119,086 shares of Globe Life common stock were outstanding when the notice was prepared. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about Globe Life’s current or prospective operations.
Globe Life Inc. (GL) executive Robert Brian Mitchell, EVP, General Counsel and CRO, reported gift transactions on 11/13/2025 (Transaction Code G). The filing shows a disposition of 2,091 shares of common stock at $0 from the Mitchell Family Trust, and an acquisition of 283 shares at $0 into an irrevocable trust for his son.
Following these transactions, reported holdings were 39,042.3294 shares indirect via the Mitchell Family Trust, 1,853.3929 shares indirect via the Son's Trust, 12,303.005 shares indirect via the Thrift Plan Trust, and 8,074 shares held directly. The footnotes note 3.1994 shares added through a brokerage dividend reinvestment plan since the last report, and that of the 2,091 shares gifted by the family trust, 283 shares were gifted to the son's irrevocable trust.
Globe Life Inc. filed a Form 13F reporting its institutional holdings as manager, showing 2 reported positions with a total reported market value of $400,198,817. The report was signed by Christopher T. Moore on 11-07-2025.
Globe Life Inc. amended its Supplemental Executive Retirement Plan (SERP). The update revises the early retirement reduction factors, setting benefit levels from 50% at age 55 up to 100% at age 65.
The amendment also provides that SERP participants who are in the Executive Severance Plan and experience a “Qualifying Termination” during a “Change of Control Protection Period” will be deemed vested and eligible for Retirement Income. In that case, the participant’s retirement age is deemed the greater of actual age or 55; the Pension Plan benefit is assumed vested, early-retirement eligible, and calculated as of the greater of actual age or 55; and no additional Credited service is included in either the Pension Plan or SERP benefit.
Globe Life Inc. filed its quarterly report for the period ended September 30, 2025. The filing presents a larger balance sheet, reflecting growth in invested assets and liquidity.
All dollar amounts are in thousands. Total assets were $30,527,616 versus $29,076,181 at December 31, 2024. Total investments were $20,326,714, up from $19,571,563, including fixed maturities at fair value of $17,796,754 (amortized cost: 2025—$18,948,357; allowance for credit losses: 2025—$10,415). Cash was $302,716, compared with $165,325.
Total liabilities were $24,838,528 versus $23,770,661. Policy liabilities were $20,626,749, up from $19,716,330, including future policy benefits at current discount rates of $19,301,965. Short‑term debt was $394,349 and long‑term debt was $2,320,013 (estimated fair value: 2025—$2,196,342).
As context, common shares outstanding were 79,605,800 as of October 31, 2025.
Globe Life Inc. (GL) reported an insider transaction by EVP, General Counsel and CRO Robert Brian Mitchell on 10/24/2025. He exercised employee stock options at $100.74, $98.32 and $103.23, acquiring 38,000, 38,000 and 15,000 shares of common stock. He then sold 40,185 shares at an average price of $133.8686 and 50,815 shares at an average price of $134.5964.
Following these transactions, his direct ownership was 8,074 shares. Indirect holdings were 41,133.3294 shares in the Mitchell Family Trust, 1,580.7839 shares in a Son's Trust, and 12,274.832 shares in a 401(k) Plan.
Globe Life (GL) filed a Form 144 notice for a proposed sale of 91,000 shares of common stock. The filing lists Apex Clearing as broker, with sales on the NYSE and an approximate sale date of 10/24/2025. The filing states an aggregate market value of $12,338,690 for the proposed sale. The seller acquired these shares via stock option exercise on 02/24/2021. Shares outstanding were 79,917,082 at the time noted; this is a baseline figure, not the amount being sold.